Global influenza diagnostics market is anticipated to grow significantly during forecast period due to growing prevalence of influenza, increasing demand for faster diagnosis and control of influenza, government initiatives in awareness and diagnostic programs, influencing the growth of influenza diagnostics market globally.
The report titled “Influenza Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2022–2030” offers strategic insights into the overall influenza diagnostics market along with the market size and estimates for the duration 2020 to 2030. The research study covers in-depth analysis of market segments based on test type and different geographical regions. In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global influenza diagnostics market, attractive investment proposition, and market positioning of key manufacturers sections.
Market size and forecast for these regional and country-level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2022-2030 are also included in this report, considering 2021 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global influenza diagnostics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global influenza diagnostics market. This report concludes with a company profiles section that highlights major information about the key players engaged in global influenza diagnostics market. In-depth competitive environment analysis and historical years (2020) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global Influenza diagnostics market, offering market size and estimates for the period from 2020 to 2030, keeping in mind the above-mentioned factors.
Influenza is an acute respiratory disease caused by influenza type A, B or C viruses infection, preventable by vaccination or chemoprophylaxis and is treatable by specific antivirals. Influenza outbreaks and epidemics pose ongoing risks to global human public health. According to World Health Organization (WHO), annually 5-15% of the population globally are affected with upper respiratory tract infections due to influenza epidemics. Growing government initiatives to counter influenza is prime factor that is driving the growth of influenza diagnostics market worldwide. There are different types of diagnostic tests available in market such as rapid influenza diagnostic tests (RIDT), real time reverse transcription polymerase chain reaction (RT-PCR), cell culture, RSV test, rapid flu tests, serology and immunofluorescence tests performed according to the availability and reason for testing. It is studied that, currently rapid influenza diagnostic tests (RIDT) held largest market share and anticipated to grow during forecast period due to its ease of use, rapid results and accuracy. Moreover, WHO recommendations on the use of rapid testing for influenza diagnosis are further driving the growth of rapid influenza diagnostic tests (RIDT) market globally. However, high rate of false-negative results may negatively impacting the growth of rapid influenza diagnostic tests (RIDT) market.
The World Health Organization (WHO) reports that throughout the world, annual outbreaks result in 3–5 million severe cases and between 250,000 and 500,000 deaths occurs due to influenza infection. Among the considered regional markets North America followed by Europe is currently dominating the influenza diagnostics market globally due to higher rate of in vitro diagnostics availability, technologically advanced medical devices and presence of key manufacturer primarily driving the market growth in these region. Government and private organization initiatives such as NIH, CDC, [J1] and the U.S. Food and Drug Administration (FDA) worked together to characterize the virus, identify a candidate vaccine strain, and expedite manufacturing fueling the market growth in North America. Asia Pacific is expected to grow at the highest CAGR during the forecast period due to the rising healthcare awareness, higher number of targeted population, increasing demand for advanced diagnostic technologies and government initiatives assisting the market growth during forecast period in Asia Pacific.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Influenza Diagnostics market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
Region Segment (2020–2030; US$ Million)
Global Impact of Covid-19 Segment (2020-2021; US$ Million )
Key questions answered in this report